chartexchange

Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors

GlobeNewswire Inc. | Oct 15, 2026 4:30 PM EDT

Financing involving participation from the CEO and Chief Commercial Officer, supports manufacturing scale-up, regulatory testing and preclinical work toward the Company’s planned FDA 510(k) submission in the first quarter of 2027 Financing involving participation from the CEO and Chief Commercial Officer, supports manufacturing scale-up, regulatory testing and preclinical work toward the Company’s planned FDA 510(k) submission in the first quarter of 2027

Read original article